![Tage Honoré](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tage Honoré
Directeur/Membre du Conseil chez
VANDA PHARMACEUTICALS INC.
Fortune : 572 030 $ au 30/06/2026
Profil
Dr. Tage Honoré is an Independent Director at Vanda Pharmaceuticals, Inc., a Head-Pharmaceutical Development at Avicenna Biosciences, Inc. and a President at Aestus Partners LLC.
He is on the Board of Directors at Vanda Pharmaceuticals, Inc. Dr. Honoré was previously employed as a Chairman by Dep-Xplora ApS.
He received his graduate degree from the University of Copenhagen and a doctorate degree from the University of Copenhagen.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2026 | 93 469 ( 0,16 % ) | 572 030 $ | 30/06/2026 |
Postes actifs de Tage Honoré
| Sociétés | Poste | Début |
|---|---|---|
| VANDA PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 15/03/2023 |
Avicenna Biosciences, Inc.
 Avicenna Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that intends to redesign and optimize drug candidates | Corporate Officer/Principal | 01/01/2020 |
Anciens postes connus de Tage Honoré
| Sociétés | Poste | Fin |
|---|---|---|
Dep-Xplora ApS
 Dep-Xplora ApS BiotechnologyHealth Technology Develops non-steroidal anti-inflammatory drugs for arthritis pain | Président | 01/03/2019 |
Formation de Tage Honoré
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dep-Xplora ApS
Dep-Xplora ApS BiotechnologyHealth Technology Develops non-steroidal anti-inflammatory drugs for arthritis pain | Health Technology |
Avicenna Biosciences, Inc.
Avicenna Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that intends to redesign and optimize drug candidates | Health Technology |
